MSK
Search
- Page Path
- HOME > Search
Research Support, Non-U.S. Gov't
- Sublingual Administration of Bacteria-Expressed Influenza Virus Hemagglutinin 1 (HA1) Induces Protection against Infection with 2009 Pandemic H1N1 Influenza Virus
- Byoung-Shik Shim , Jung-ah Choi , Ho-Hyun Song , Sung-Moo Park , In Su Cheon , Ji-Eun Jang , Sun Je Woo , Chung Hwan Cho , Min-Suk Song , Hyemi Kim , Kyung Joo Song , Jae Myun Lee , Suhng Wook Kim , Dae Sub Song , Young Ki Choi , Jae-Ouk Kim , Huan Huu Nguyen , Dong Wook Kim , Young Yil Bahk , Cheol-Heui Yun , Man Ki Song
- J. Microbiol. 2013;51(1):130-135. Published online March 2, 2013
- DOI: https://doi.org/10.1007/s12275-013-2399-z
- 27 View
- 0 Download
- 13 Crossref
-
Abstract
- Influenza viruses are respiratory pathogens that continue to pose a significantly high risk of morbidity and mortality of humans worldwide. Vaccination is one of the most effective strategies for minimizing damages by influenza outbreaks. In addition, rapid development and production of efficient vaccine with convenient administration is required in case of influenza pandemic. In this study, we generated recombinant influenza virus hemagglutinin protein 1 (sHA1) of 2009 pandemic influenza virus as a vaccine candidate using a wellestablished bacterial expression system and administered it into mice via sublingual (s.l.) route. We found that s.l. immunization with the recombinant sHA1 plus cholera toxin (CT) induced mucosal antibodies as well as systemic antibodies including neutralizing Abs and provided complete protection against infection with pandemic influenza virus A/CA/04/09 (H1N1) in mice. Indeed, the protection efficacy was comparable with that induced by intramuscular (i.m.) immunization route utilized as general administration route of influenza vaccine. These results suggest that s.l. vaccination with the recombinant non-glycosylated HA1 protein offers an alternative strategy to control influenza outbreaks including pandemics.
-
Citations
Citations to this article as recorded by
-
Immunomodulatory Effects of Probiotic
Lactobacillus casei
On GM-CSF-adjuvanted Influenza Dna Vaccine
Mehran Mahooti, Elahe Abdolalipour, Behrokh Farahmand, Sadegh Shirian, Amir Ghaemi
Future Virology.2022; 17(9): 633. CrossRef - Structural Insights for Anti-Influenza Vaccine Design
Lifen Han, Cong Chen, Xianlin Han, Shujin Lin, Xiulan Ao, Xiao Han, Jianmin Wang, Hanhui Ye
Computational and Structural Biotechnology Journal.2019; 17: 475. CrossRef - La vacuna sublingual de la gripe
J. Reina
Vacunas.2019; 20(1): 37. CrossRef - The sublingual influenza vaccine
J. Reina
Vacunas (English Edition).2019; 20(1): 37. CrossRef - The effect of aqueous extract of Xinjiang Artemisia rupestris L. (an influenza virus vaccine adjuvant) on enhancing immune responses and reducing antigen dose required for immunity
Ailian Zhang, Danyang Wang, Jinyao Li, Feng Gao, Xucheng Fan, Farhat Afrin
PLOS ONE.2017; 12(8): e0183720. CrossRef - HA1-2-fljB Vaccine Induces Immune Responses against Pandemic Swine-Origin H1N1 Influenza Virus in Mice
Xilong Kang, Yun Yang, Yang Jiao, Hongqin Song, Li Song, Dan Xiong, Lili Wu, Zhiming Pan, Xinan Jiao
Microbial Physiology.2016; 26(6): 422. CrossRef - A De-O-acylated Lipooligosaccharide-Based Adjuvant System Promotes Antibody and Th1-Type Immune Responses to H1N1 Pandemic Influenza Vaccine in Mice
Ji In Ryu, Shin Ae Park, Seo Ri Wui, Ara Ko, Ji Eun Han, Jung Ah Choi, Man Ki Song, Kwang Sung Kim, Yang Je Cho, Na Gyong Lee
BioMed Research International.2016; 2016: 1. CrossRef - A Lipopolysaccharide from Pantoea Agglomerans Is a Promising Adjuvant for Sublingual Vaccines to Induce Systemic and Mucosal Immune Responses in Mice via TLR4 Pathway
Masahiro Fukasaka, Daisuke Asari, Eiji Kiyotoh, Arimichi Okazaki, Yasuyuki Gomi, Takeshi Tanimoto, Osamu Takeuchi, Shizuo Akira, Mitsuhiko Hori, John S Tregoning
PLOS ONE.2015; 10(5): e0126849. CrossRef - Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually
Justin L. Spinner, Hardeep S. Oberoi, Yvonne M. Yorgensen, Danielle S. Poirier, David J. Burkhart, Martin Plante, Jay T. Evans
Vaccine.2015; 33(43): 5845. CrossRef - Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice
Jianjun Chen, Qian Liu, Quanjiao Chen, Chaochao Xiong, Yanfeng Yao, Huadong Wang, Hanzhong Wang, Ze Chen
Archives of Virology.2014; 159(4): 689. CrossRef - Sublingual Delivery of Vaccines for the Induction of Mucosal Immunity
Byoung-Shik Shim, Youngjoo Choi, In Su Cheon, Man Ki Song
Immune Network.2013; 13(3): 81. CrossRef - Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection
So-Hee Kim, Joo Young Kim, Youngjoo Choi, Huan H. Nguyen, Man Ki Song, Jun Chang, Eui-Cheol Shin
PLoS ONE.2013; 8(9): e75460. CrossRef - Immunogenicity and safety of H1N1 influenza hemagglutinin protein expressed in a baculovirus system
Ha‐Na Na, Kyung Hyun Kim, Man Ki Song, Hye‐lim Park, Eun‐young Lee, Seung‐Hyun Shim, Sooho Park, Jae‐Hwan Nam
Microbiology and Immunology.2013; 57(9): 660. CrossRef
-
Immunomodulatory Effects of Probiotic
Lactobacillus casei
On GM-CSF-adjuvanted Influenza Dna Vaccine
First
Prev
TOP
